MedPath

CHI-921

Generic Name
CHI-921

Investigation of the Efficacy and Safety of CHI-921 in Insomnia.

Phase 2
Terminated
Conditions
Insomnia
Interventions
Drug: Placebo
First Posted Date
2019-06-13
Last Posted Date
2020-10-05
Lead Sponsor
Canopy Growth Corporation
Target Recruit Count
21
Registration Number
NCT03984604
Locations
🇨🇦

Algorithme Pharma Inc., Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath